Clinical trial
Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients
NCT00042432 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00042432 |
|---|---|
| Title | Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients |
| Official title | A Study of an Investigational Medication for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Secondary Hyperparathyroidism, Chronic Renal Insufficiency |
| Intervention type | Drug |
| Interventions | cinacalcet (AMG 073) |
| Enrollment | 54 |
| Start date | Jun 1, 2002 |
| Primary completion | Mar 1, 2003 |
| Completion | Aug 1, 2003 |
| First posted | Aug 1, 2002 |
| Last update posted | May 13, 2013 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: